FeesSafety
Pluang+

Mineralys Therapeutics to present at three upcoming investor conferences in November and December 2026

Market News
03 Nov 2026, 23:05 WIB
GlobeNewsWire
View Source
Neutral
Mineralys Therapeutics to present at three upcoming investor conferences in November and December 2026

Mineralys Therapeutics, a biopharmaceutical company developing treatments for hypertension and related conditions, announced that its senior management will participate in fireside chats at three investor conferences in November and December 2026. These events include the Guggenheim Healthcare Innovation Conference on November 10, the Stifel Healthcare Conference on November 12, and the Evercore Healthcare Conference on December 1. The company’s presentations will provide updates on its progress, including its lead drug candidate lorundrostat, which targets aldosterone-related diseases. Investors can access live webcasts and archives on Mineralys' website.

Mineralys Therapeutics' upcoming investor conference participation is noted here with Pluang's health sector data for context. Of 150 priced health-sector US stocks on Pluang, 92 rose and 55 fell today. Notable movers include TNGX at USD 23.17 with a 6.48% increase and a typical hold time of 4 days, TXG at USD 65.43 with a 6.17% rise and 60% buy order activity, as of Nov 04, 2026 04:11 WIB.

More News

Vencora acquires CT InsureTech to boost insurance tech portfolio and expand in Latin America.

Vencora acquires CT InsureTech to boost insurance tech portfolio and expand in Latin America.

Vencora has acquired CT InsureTech, a leading insurance technology provider with offices in London, Buenos Aires, and Mexico City. This acquisition strengthens Vencora's insurance technology offerings and expands its presence in Latin America and Eur...

Company Fundamentals
Bullish
4 hours ago
Vencora acquires CT InsureTech to boost insurance tech and expand in Latin America and UK

Vencora acquires CT InsureTech to boost insurance tech and expand in Latin America and UK

Vencora has acquired CT InsureTech, a leading provider of insurance technology and services with offices in London, Buenos Aires, and Mexico City. This acquisition expands Vencora's portfolio and presence in Latin America and the UK, strengthening it...

Company Fundamentals
Bullish
4 hours ago
Postal Realty Trust reports Q3 2026 net income of $0.16/share and raises 2026 acquisition guidance to $185-$200M.

Postal Realty Trust reports Q3 2026 net income of $0.16/share and raises 2026 acquisition guidance to $185-$200M.

Postal Realty Trust, Inc. announced a net income of $0.16 per diluted share for Q3 2026, driven by acquisitions of 145 USPS properties worth $82 million and a 25.2% increase in rental income year-over-year. The company raised its 2026 acquisition gui...

Company Fundamentals
Bullish
5 hours ago
Crescent Biopharma grants stock options to new employee as inducement under Nasdaq rules.

Crescent Biopharma grants stock options to new employee as inducement under Nasdaq rules.

Crescent Biopharma awarded stock options for 11,775 shares to a new non-executive employee as part of an inducement plan approved by its Compensation Committee. The options have a 10-year term with an exercise price of $12.91, matching the closing sh...

Company Fundamentals
Neutral
5 hours ago
HP Inc. to report Q4 fiscal 2026 earnings on Nov 24 and attend key investor conferences in December

HP Inc. to report Q4 fiscal 2026 earnings on Nov 24 and attend key investor conferences in December

HP Inc. will announce its financial results for the fourth quarter and full fiscal year ending October 31, 2026, on November 24, 2026, via a live webcast. The company will also participate in several investor conferences in December, including UBS Gl...

Company Fundamentals
Neutral
5 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App